Previously, the same group had shown that MAO-A upregulation in prostate stromal fibroblasts promotes tumorigenesis via ROS generation and TWIST1-mediated paracrine IL-6/STAT3 signaling, responsible for increasing CD44 in prostate cancer cells which points to the maintenance of a de-differentiated phenotype. The gene discussed is CD44; the disease is prostate carcinoma.